Byuksan Corp
KRX:007210
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 667
2 525
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Byuksan Corp stock under the Base Case scenario is 2 596.24 KRW. Compared to the current market price of 1 769 KRW, Byuksan Corp is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Byuksan Corp.
| US |
F
|
Fortune Brands Home & Security Inc
LSE:0IRN
|
|
| IE |
|
Trane Technologies PLC
NYSE:TT
|
|
| IE |
|
Johnson Controls International PLC
NYSE:JCI
|
|
| FR |
|
Compagnie de Saint Gobain SA
PAR:SGO
|
|
| US |
|
Carrier Global Corp
NYSE:CARR
|
|
| SE |
|
Assa Abloy AB
STO:ASSA B
|
|
| JP |
|
Daikin Industries Ltd
TSE:6367
|
|
| CH |
|
Geberit AG
SIX:GEBN
|
|
| US |
|
Lennox International Inc
NYSE:LII
|
|
| IE |
K
|
Kingspan Group PLC
ISEQ:KRX
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Byuksan Corp
Balance Sheet Decomposition
Byuksan Corp
| Current Assets | 298.7B |
| Cash & Short-Term Investments | 137.8B |
| Receivables | 106.5B |
| Other Current Assets | 54.3B |
| Non-Current Assets | 395B |
| Long-Term Investments | 80.7B |
| PP&E | 299.3B |
| Intangibles | 7.2B |
| Other Non-Current Assets | 7.7B |
| Current Liabilities | 211.9B |
| Accounts Payable | 55.4B |
| Accrued Liabilities | 3.9B |
| Short-Term Debt | 94.9B |
| Other Current Liabilities | 57.7B |
| Non-Current Liabilities | 189.6B |
| Long-Term Debt | 92.2B |
| Other Non-Current Liabilities | 97.4B |
Free Cash Flow Analysis
Byuksan Corp
| KRW | |
| Free Cash Flow | KRW |
Earnings Waterfall
Byuksan Corp
|
Revenue
|
607.6B
KRW
|
|
Cost of Revenue
|
-494.6B
KRW
|
|
Gross Profit
|
113B
KRW
|
|
Operating Expenses
|
-97.2B
KRW
|
|
Operating Income
|
15.7B
KRW
|
|
Other Expenses
|
653.6m
KRW
|
|
Net Income
|
16.4B
KRW
|
Profitability Score
Profitability Due Diligence
Byuksan Corp's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Byuksan Corp's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Byuksan Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Byuksan Corp's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Byuksan Corp
According to Wall Street analysts, the average 1-year price target for Byuksan Corp is 2 754 KRW with a low forecast of 2 727 KRW and a high forecast of 2 835 KRW.
Dividends
Current shareholder yield for Byuksan Corp is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Byuksan Corp stock under the Base Case scenario is 2 596.24 KRW.
Compared to the current market price of 1 769 KRW, Byuksan Corp is Undervalued by 32%.